| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2011 | 2010 | 2009 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,4 M € | +70.5% | 3,8 M € | -37.5% | 6,0 M € | +27.4% | 4,7 M € | +24.1% | 3,8 M € | -19.8% | 4,7 M € | +2.0% | 4,7 M € | +3.5% | 4,5 M € | +3.6% | 4,3 M € | +26.2% | 3,4 M € | +3.0% | 3,3 M € | -5.6% | 3,5 M € | +9.2% | 3,2 M € | -9.3% | 3,6 M € | +22.7% | 2,9 M € | -37.6% | 4,7 M € | +22.9% | 3,8 M € | +142.4% | 1,6 M € | |
| Gross margin | 4,3 M € | +102.4% | 2,1 M € | -45.4% | 3,9 M € | +38.1% | 2,8 M € | +37.1% | 2,1 M € | -31.4% | 3,0 M € | +3.7% | 2,9 M € | -1.0% | 2,9 M € | +8.2% | 2,7 M € | +31.0% | 2,1 M € | +0.1% | 2,1 M € | -6.7% | 2,2 M € | +13.8% | 1,9 M € | -17.9% | 2,4 M € | +32.7% | 1,8 M € | -51.0% | 3,6 M € | +38.4% | 2,6 M € | +311.5% | 637,7 k € | |
| EBITDA | 2,6 M € | +394.6% | 535,5 k € | -72.6% | 2,0 M € | +85.0% | 1,1 M € | +118.6% | 482,4 k € | -65.9% | 1,4 M € | -3.5% | 1,5 M € | -2.2% | 1,5 M € | +10.4% | 1,4 M € | +39.5% | 974,0 k € | -2.9% | 1,0 M € | -14.0% | 1,2 M € | +24.8% | 934,7 k € | -31.3% | 1,4 M € | +53.2% | 887,5 k € | -63.4% | 2,4 M € | +63.9% | 1,5 M € | +949.1% | 141,0 k € | |
| Operating profit | 2,1 M € | +9076.7% | -23,1 k € | -101.6% | 1,4 M € | +161.8% | 549,1 k € | +1780.8% | 29,2 k € | -97.0% | 968,7 k € | -6.7% | 1,0 M € | +2.1% | 1,0 M € | +29.3% | 786,5 k € | +86.0% | 423,0 k € | -3.3% | 437,3 k € | -28.2% | 608,9 k € | +61.0% | 378,1 k € | -48.8% | 738,3 k € | +60.3% | 460,6 k € | -74.7% | 1,8 M € | +116.9% | 840,2 k € | +287.4% | -448,3 k € | |
| Profit/loss | 1,6 M € | +2996.6% | 52,6 k € | -95.3% | 1,1 M € | +146.1% | 457,9 k € | +402.8% | 91,1 k € | -86.9% | 696,7 k € | -5.7% | 738,6 k € | -7.2% | 795,8 k € | +50.4% | 529,1 k € | +89.5% | 279,2 k € | -3.0% | 287,7 k € | -20.0% | 359,6 k € | +4.3% | 344,7 k € | -28.5% | 482,0 k € | +120.3% | 218,8 k € | -80.6% | 1,1 M € | +83.2% | 615,0 k € | +181.5% | -754,8 k € | |
| Equity | 4,9 M € | +47.0% | 3,3 M € | -2.1% | 3,4 M € | -2.0% | 3,5 M € | -2.0% | 3,5 M € | -2.0% | 3,6 M € | -1.9% | 3,7 M € | -1.0% | 3,7 M € | -1.1% | 3,7 M € | -1.9% | 3,8 M € | -2.1% | 3,9 M € | +1.9% | 3,8 M € | +1.8% | 3,8 M € | -1.3% | 3,8 M € | -2.1% | 3,9 M € | -1.9% | 4,0 M € | +2.9% | 3,9 M € | +47.4% | 2,6 M € | |
| Total assets | 6,5 M € | +14.7% | 5,6 M € | +2.4% | 5,5 M € | +13.6% | 4,8 M € | +1.4% | 4,8 M € | -20.7% | 6,0 M € | -5.0% | 6,3 M € | -10.7% | 7,1 M € | -0.8% | 7,2 M € | -1.0% | 7,2 M € | -4.6% | 7,6 M € | -5.1% | 8,0 M € | -8.2% | 8,7 M € | -7.7% | 9,4 M € | -6.6% | 10,1 M € | -12.5% | 11,6 M € | +4.7% | 11,0 M € | +7.3% | 10,3 M € | |
| Cash | 2,6 M € | +73.3% | 1,5 M € | +52.8% | 970,7 k € | +36.3% | 712,4 k € | +54.3% | 461,7 k € | -65.6% | 1,3 M € | -5.8% | 1,4 M € | -17.3% | 1,7 M € | +20.2% | 1,4 M € | +6.9% | 1,3 M € | +3.1% | 1,3 M € | +3.2% | 1,3 M € | +1.8% | 1,2 M € | -17.8% | 1,5 M € | +257.9% | 420,5 k € | -80.7% | 2,2 M € | +1636.1% | 125,3 k € | -50.7% | 254,1 k € | |
| Debts | 1,6 M € | -31.5% | 2,3 M € | +9.6% | 2,1 M € | +52.4% | 1,4 M € | +10.8% | 1,3 M € | -48.5% | 2,4 M € | -9.2% | 2,7 M € | -21.2% | 3,4 M € | +0.6% | 3,4 M € | -1.2% | 3,4 M € | -7.2% | 3,7 M € | -11.6% | 4,2 M € | -15.9% | 5,0 M € | -12.1% | 5,6 M € | -9.4% | 6,2 M € | -18.0% | 7,6 M € | +6.4% | 7,1 M € | -6.9% | 7,7 M € | |
| Staff | 23,9 | 24,5 | 32,3 | 30,9 | 32,6 | 32,3 | 30,1 | 29,7 | 29,4 | 25,6 | 22,6 | 21,6 | 21,3 | 22,2 | 25,4 | 30,9 | 30,1 | 10,1 | ||||||||||||||||||
Public limited company · Marche-en-Famenne · incorporated on 03/05/2007 · 23,9 ETP
Public limited company profitable and well capitalised. Cash position rising (+73.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
THYMOLUX is a Public limited company incorporated in 2007. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Marche-en-Famenne. It employs on average 23,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette